Mark Van Oene - 17 Feb 2026 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Signature
/s/ Michele Farmer, Attorney-in-fact
Issuer symbol
PACB
Transactions as of
17 Feb 2026
Net transactions value
-$294,318
Form type
4
Filing time
19 Feb 2026, 20:33:35 UTC
Previous filing
20 Aug 2025
Next filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Van Oene Mark Chief Operating Officer PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,, 1305 O'BRIEN DRIVE, MENLO PARK /s/ Michele Farmer, Attorney-in-fact 19 Feb 2026 0001707477

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PACB Common Stock Sale $204,549 -129,790 -6.7% $1.58 1,797,745 17 Feb 2026 Direct F1, F2, F3
transaction PACB Common Stock Sale $89,769 -55,107 -3.1% $1.63 1,742,638 18 Feb 2026 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares mandatorily sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $1.51 to $1.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 Includes 7,500 shares purchased on September 2, 2025 under the Company's 2010 Employee Stock Purchase Plan.
F4 This sale price represents the weighted average sale price of the shares sold ranging from $1.55 to $1.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Remarks:

Chief Operating Officer